The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
about
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemiasEmerging therapy for the treatment of acute lymphoblastic leukemia.Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents
P2860
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
@en
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
@nl
type
label
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
@en
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
@nl
prefLabel
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
@en
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
@nl
P2093
P356
P1476
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
@en
P2093
Alexander W Brown
Bradley A McGregor
Michael B Osswald
P304
P356
10.1002/AJH.21365
P577
2009-04-01T00:00:00Z